The H1c haplotype at the MAPT locus is associated with Alzheimer's disease

Human Molecular Genetics

Volumn 14, Issue 16, 2005, Pages 2399-2404

  Myers, A J ^a   Kaleem, M ^a   Marlowe, L ^a   Pittman, A M ^b,c   Lees, A J ^b,c   Fung, H C ^a,b,d   Duckworth, J ^a   Leung, D ^a   Gibson, A ^e   Morris, C M ^e   de Silva, R ^b,c   Hardy, J ^a,b,c  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLADISTICS; CONTROLLED STUDY; GENE LOCUS; GENETIC LINKAGE; GENETIC RISK; HAPLOTYPE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 26444463460     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi241     Document Type: Article

References (20)

1. Dickson, D.W. (2001) Neuropathology of Alzheimer's disease and other dementias. [i#Clin. Geriatr. Med.#1i], [b#17#1b], 209-228.
2. Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E. and Hutton, M. (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. [i#Hum. Mol. Genet.#1i], [b#8#1b], 711-715.
3. Houlden, H., Baker, M., Morris, H.R., MacDonald, N., Pickering-Brown, S., Adamson, J., Lees, A.J., Rossor, M.N., Quinn, N.P., Kertesz, A. [i#et al.#1i] (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. [i#Neurology#1i], [b#56#1b], 1702-1706.
4. Pittman, A.M., Myers, A.J., Duckworth, J., Bryden, L., Hanson, M., Abou-Sleiman, P., Wood, N.W., Hardy, J., Lees, A. and de Silva, R. (2004) The structure of the tau haplotype in controls and in progressive supranuclear palsy. [i#Hum. Mol. Genet.#1i], [b#13#1b], 1267-1274.
5. Skipper, L., Wilkes, K., Toft, M., Baker, M., Lincoln, S., Hulihan, M., Ross, O.A., Hutton, M., Aasly, J. and Farrer, M. (2004) Linkage disequilibrium and association of MAPT H1 in Parkinson disease. [i#Am. J. Hum. Genet.#1i], [b#75#1b], 669-677.
6. Pastor, P., Ezquerra, M., Perez, J.C., Chakraverty, S., Norton, J., Racette, B.A., McKeel, D., Perlmutter, J.S., Tolosa, E. and Goate, A.M. (2004) Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. [i#Ann. Neurol.#1i], [b#56#1b], 249-258.
7. Oliveira, S.A., Scott, W.K., Zhang, F., Stajich, J.M., Fujiwara, K., Hauser, M., Scott, B.L., Pericak-Vance, M.A., Vance, J.M. and Martin, E.R. (2004) Linkage disequilibrium and haplotype tagging polymorphisms in the tau H1 haplotype. [i#Neurogenetics#1i], [b#5#1b], 147-155.
8. Pittman, A.M., Myers, A.J., Abou-Sleiman, P., Fung, H.C., Kaleem, M., Marlowe, L., Duckworth, J., Leung, D., Williams, D., Kilford, L. [i#et al.#1i] (2005). Linkage disequilibrium fine-mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. [i#J. Med. Genet.#1i], doi:10.1136/ jmg.2005.031377.
9. Crawford, F., Freeman, M., Town, T., Fallin, D., Gold, M., Duara, R. and Mullan, M. (1999) No genetic association between polymorphisms in the tau gene and Alzheimer's disease in clinic or population based samples. [i#Neurosci. Lett.#1i], [b#266#1b], 193-196.
10. Lilius, L., Froelich Fabre, S., Basun, H., Forsell, C., Axelman, K., Mattila, K., Andreadis, A., Viitanen, M., Winblad, B., Fratighoni, L. and Lannfelt, L. (1999) Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease. [i#Neurosci. Lett.#1i], [b#277#1b], 29-32.
11. Bullido, M.J., Aldudo, J., Frank, A., Coria, F., Avila, J. and Valdivieso, F. (2000) A polymorphism in the tau gene associated with risk for Alzheimer's disease. [i#Neurosci. Lett.#1i], [b#278#1b], 49-52.
12. Green, E.K., Thaker, U., McDonagh, A.M., Iwatsubo, T., Lambert, J.C., Chartier-Harlin, M.C., Harris, J.M., Pickering-Brown, S.M., Lendon, C.L. and Mann, D.M. (2002) A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain. [i#Neurosci. Lett.#1i], [b#324#1b], 113-116.
13. Roks, G., Dermaut, B., Heutink, P., Julliams, A., Backhovens, H., Van de Broeck, M., Serneels, S., Holman, A., Van Broeckhoven, C., van Duijn, C.M. and Cruts, M. (1999) Mutation screening of the tau gene in patients with early-onset Alzheimer's disease. [i#Neurosci. Lett.#1i], [b#277#1b], 137-139.
14. Russ, C., Powell, J.F., Zhao, J., Baker, M., Hutton, M., Crawford, F., Mullan, M., Roks, G., Cruts, M. and Lovestone, S. (2001) The microtubule associated protein tau gene and Alzheimer's disease - an association study and meta-analysis. [i#Neurosci. Lett.#1i], [b#314#1b], 92-96.
15. Hardy, J. and Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. [i#Science#1i] [b#297#1b], 353-356.
16. Lewis, J., Dickson, D.W., Lin, W.L., Chisholm, L., Corral, A., Jones, G., Yen, S.H., Sahara, N., Skipper, L., Yager, D. [i#et al.#1i] (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. [i#Science#1i], [b#293#1b], 1487-1491.
17. Hardy, J., Duff, K., Hardy, K.G., Perez-Tur, J. and Hutton, M. (1998) Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau. [i#Nat. Neurosci.#1i], [b#1#1b], 355-358.
18. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y. and LaFerla, F.M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. [i#Neuron#1i], [b#39#1b], 409-421.
19. Rapoport, M., Dawson, H.N., Binder, L.I., Vitek, M.P. and Ferreira, A. (2002) Tau is essential to beta-amyloid-induced neurotoxicity. [i#Proc. Natl Acad. Sci. USA#1i], [b#99#1b], 6364-6369.
20. Singleton, A., Myers, A. and Hardy, J. (2004) The law of mass action applied to neurodegenerative disease: A hypothesis concerning the etiology and pathogenesis of complex diseases. [i#Hum. Mol. Genet.#1i], [b#13#1b], R123-R126.